Two EPFL spin-offs reach the finals of an international competition

EPFL spinoffs Lumendo and Gliapharm are among 80 deep-tech startups from around the world that have qualified for the finals of the Hello Tomorrow Challenge in Paris tomorrow. The finalists will pitch their company to a jury of technology specialists and investors. In addition to vying for cash prizes, the startups are gaining valuable visibility. Gliapharm and Lumendo will pitch the jury in Paris tomorrow at the Hello Tomorrow Challenge. This is one of the leading biotechnology startup competitions in Europe, designed to showcase deep-tech startups that are working on complex engineering processes or using existing technology in an innovative way. Five hundred companies made it into the competition, but only 80 of those have made it to the finals - and they will square off tomorrow in Paris. The two EPFL startups have their sights set on the top prize of 100,000 euros, but they will also make the most of the international visibility that they are gaining.